Docket #: S12-334
Mouse Strain C57BL/6J-Tg (ACTB-DDAH1) - Jackson Labs, Stock Number: 005863
Hemizygous mice are viable and fertile with no anatomic abnormalities. Transgene expression is observed in aorta, heart, and brain. Transgenicdimethylarginine dimethylaminohydrolase (DDAH) activity is reflected in a reduction of plasma asymmetric dimethylarginine (ADMA). Nitric oxide synthase (NOS) activity is significantly increased in trnasgenic skeletal and cardiac muscle. Transgenic mice have lower blood pressure and higher heart rate. Transgenic mice may be useful in studies of atherosclearosis, hypertension, hyperlipidemia, hypercholesterolemia, hyperhomocystinemia, diabetes mellitus, stroke, renal failure, preeclampsia, and other conditions associated with vascular pathophysiology and/or cardiovascular disease.
Jackson Labs Stock Number: 005863
(For-profit companies will need a license from Stanford prior to receiving the mice from Jackson Labs)
Similar Technologies
-
Transgenic Mouse as a Donor of Labeled Cells and Tissues (B6;FVB-Ptprca Tg(CAG-luc,-GFP)L2G85Chco Thy1a/J) - Jackson Labs stock number 025854 S15-470Transgenic Mouse as a Donor of Labeled Cells and Tissues (B6;FVB-Ptprca Tg(CAG-luc,-GFP)L2G85Chco Thy1a/J) - Jackson Labs stock number 025854
-
Controlling AAV receptor expression to improve testing and validation of AAV gene therapy products S15-240Controlling AAV receptor expression to improve testing and validation of AAV gene therapy products
-
L2G85 mouse strain: Jax lab stock number 010548 D1.FVB(Cg)-Tg(CAG-luc)L2G85Chco Jax lab stock number 010545 C.FVB-Tg(CAG-luc,-GFP)L2G85Chco S55-609DL2G85 mouse strain: Jax lab stock number 010548 D1.FVB(Cg)-Tg(CAG-luc)L2G85Chco Jax lab stock number 010545 C.FVB-Tg(CAG-luc,-GFP)L2G85Chco